Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...
The Canadian Press on MSN2d
Health Canada approves Moderna's mRNA RSV vaccine, company saysHealth Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older — ...
The Canadian Press on MSN3d
Today-History-Nov23Today in History for Nov. 23: ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
The Maravi Post ...
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...
CHAOS THEORY — On the eve of Election Day, it’s worth taking one last look at how chaos could break out as we wait for ...
CNW/ - The 2025 Lung Ambition Awards – a Canadian-based lung cancer research award program – is now open for submissions. For ...
Some provinces have begun rolling out a vaccination program for infants with newly authorized products. The situation is much ...
The decision by the regional board will likely give ammunition to vaccine-sceptics and anti-vaxxers who pushed against the ...
The UK's benchmark FTSE 100 index fell on Wednesday, dragged by healthcare shares after GSK warned of lower annual vaccine ...
Despite today's fall in Pfizer's share price, it beat my and Wall Street analysts' expectations for Q3 by a large margin. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback